// App-Quantinova.ai

532 : Prognostic value of a BCSC-associated microRNA signature in hormone receptor-positive HER2-negative breast cancer.

Researchers

Presenter

  • Chang Gong

Principal Investigators

  • Weige Tan

  • Kai Chen

  • Na You

  • Shan Zhu

  • Wei Luo

  • Xinhua Xie

  • Yunjie Zeng

  • Nengtai Ouyang

  • Zhihua Li

  • Musheng Zeng

  • Shimei Zhuang

  • Wan-Yee Lau

  • Qiang Liu

  • Fengxi Su

  • Xueqin Wang

  • Erwei Song

Medical Centers

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

  • Department of Statistical Science, School of Mathematics and Computational Science & Southern China Research Center of Statistical Science, Sun Yat-sen University, Guangzhou, China

  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Department of Biotherapy, Guangzhou, China

  • Department of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China

  • Prevention and Cure Center of Breast Disease, Key Laboratory of Breast disease, the Third Hospital of Nanchang City, Nanchang, China

  • Key Laboratory of Gene Engineering of Ministry of Education, Collaborative Innovation Center for Cancer Medicine, School of Life Science, Sun Yat-sen University, Guangzhou, China

  • Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, Hong Kong, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final